McKesson

On April 15, 2021, Dr. N. Anthony Coles informed the Company that he will not stand for re-election at the Company’s 2021 Annual Meeting. Dr. Coles has served as a member of the Board since 2014 and currently serves as a member of the Compensation Committee and the Finance Committee. Dr. Coles will continue to serve as a director and in his committee roles until the 2021 Annual Meeting, to be held on July 23, 2021. The Board expressed its appreciation to Dr. Coles for his service to the Company.

On October 15, 2020, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected Linda P. Mantia as a director, effective on October 19, 2020. Ms. Mantia served as Senior Executive Vice President, Chief Operating Officer of Manulife Financial Corporation, an international insurance and financial services company, from 2016 to 2019. Before her role at Manulife, Ms. Mantia served as Executive Vice President of Digital, Payments and Cards at Royal Bank of Canada (RBC), a multinational financial services company, from 2014 to 2016. During her tenure at RBC, she also served in other leadership roles from 2003 to 2014, including Executive Vice President of Global Cards and Payments. Earlier in her career, Ms. Mantia worked at McKinsey & Co., a global management consulting firm, and prior to that, she practiced law at Davies Ward Phillips & Vineberg LLC.

McKesson Corporation today announced Bansi Nagji, Executive Vice President and Chief Strategy and Business Development Officer, will step down as an executive officer effective March 31, 2020. Mr. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. In the context of the company headquarters move from San Francisco to Dallas, the Compensation Committee approved separation payments to Mr. Nagji in an amount equal to the amount he would be entitled to under the previously-disclosed Severance Policy for Executive Employees, but without offset for compensation from any new employment secured during the payment period. The terms of the policy are described in the Corporation’s proxy statement.

On October 17, 2019, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected Maria Martinez as a director, effective on October 18, 2019. Ms. Martinez, age 61, has served as Executive Vice President and Chief Customer Experience Officer at Cisco Systems, Inc. since April 2018. Previous to her role at Cisco, Ms. Martinez served in a variety of senior executive roles at salesforce.com, inc. including President, Global Customer Success and Latin America from March 2016 to April 2018; President, Sales and Customer Success from February 2013 to March 2016; Executive Vice President and Chief Growth Officer from February 2012 to February 2013; and Executive Vice President, Customers for Life from February 2010 to February 2012.

On June 16, 2019, the Board of Directors (“Board”) of McKesson Corporation (“Company”) elected Kenneth E. Washington as a director, effective on July 1, 2019. Dr. Washington, age 58, has served as chief technology officer (CTO) of Ford Motor Company since June 2017. In this role, he leads Ford’s worldwide research organization, and oversees the development and implementation of Ford’s technology strategy and plans. Prior to his role as CTO, Dr. Washington was appointed Ford’s vice president of Research and Advanced Engineering in August 2014. Previously, Dr. Washington was vice president of the Advanced Technology Center at Lockheed Martin Space Systems Company. He also served as Lockheed Martin Corporation’s first chief privacy officer, a role in which he built the company’s privacy program.

On April 23, 2019, Jorge Figueredo, Executive Vice President and Chief Human Resources Officer, who is a named executive officer of McKesson Corporation (“Company”), gave the Company notice of his decision to retire from the Company effective on September 30, 2019. Mr. Figueredo will receive one additional “point” for purposes of the age plus years of service calculation under certain Company incentive plans, such that certain long-term cash and equity awards granted to him in the last two years will vest in accordance with their original terms, including their original performance conditions. Mr. Figueredo will also receive his fiscal year 2020 annual cash bonus on a prorated basis to reflect the partial year of service prior to his retirement, along with other standard benefits.

On March 26, 2019, the Board of Directors of McKesson Corporation (the “Company”) appointed Brian S. Tyler, President and Chief Operating Officer of the Company, to the Board of Directors effective April 1, 2019 to fill the vacancy created by the retirement of John H. Hammergren effective March 31, 2019. Mr. Tyler was appointed to serve as a director until the Company’s next annual meeting of stockholders or until his successor is duly elected and qualified. As previously disclosed, Mr. Tyler also will assume the role of Chief Executive Officer of the Company effective April 1, 2019 upon Mr. Hammergren’s retirement as Chief Executive Officer and Chairman of the Board of the Directors of the Company effective March 31, 2019. Mr.

On March 15, 2019, McKesson Corporation (the “Company”) and John H. Hammergren, Chief Executive Officer and Chairman of the board of directors of the Company, entered into a Senior Advisor Agreement that will go into effect April 1, 2019. The agreement is terminable by either party at any time with six months’ notice provided, however, that the agreement will terminate no later than the date the Company no longer has the right to appoint any directors to the board of Change Healthcare, LLC. The agreement provides for a monthly consulting fee of $75,000. Mr. Hammergren will not be entitled to any additional compensation or benefits as a result of this agreement, other than those payments or benefits to which he was already entitled under his employment agreement in connection with his retirement. The foregoing description of Mr.

As previously announced on November 1, 2018, John H. Hammergren will retire from his roles as Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of McKesson Corporation (the “Company”), effective March 31, 2019, and Brian S. Tyler will assume the role of Chief Executive Officer on April 1, 2019. In connection with Mr. Tyler assuming the role of Chief Executive Officer, the Compensation Committee of the Board approved changes to his compensation, all of which are effective April 1, 2019. Mr. Tyler’s annual base salary will be $1,250,000, his target annual bonus opportunity under the Management Incentive Plan will be 150% of his salary earned during the performance period, and his target long-term incentives (cash and equity) will be $9,875,000.

On April 25, 2018, McKesson Corporation announced a multi-year strategic growth initiative focused on creating innovative new solutions that improve patient care delivery, which is intended to drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and enhance sustained long-term performance. As part of this initiative, our growth priorities include expanded supply chain and commercialization services for pharmaceutical and medical supply manufacturers, enhanced solutions for the rapidly growing specialty pharmaceutical market, and new offerings that will strengthen and expand the role of retail pharmacy in patient care delivery. Last week, we announced that Mr. John H.

On October 30, 2018, John H. Hammergren decided to retire from his roles as Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of McKesson Corporation (the “Company”), effective as of March 31, 2019. The Board has appointed Brian S. Tyler, currently the Company’s President and Chief Operating Officer, as Chief Executive Officer effective April 1, 2019. The Board also expects to appoint Mr. Tyler to the Board effective April 1, 2019. Mr. Tyler, age 51, has served as President and Chief Operating Officer of the Company since August 2018, and previously served as Chairman of the Management Board of McKesson Europe AG since 2017. Mr.

On September 12, 2018, the Board of Directors (the “Board”) of McKesson Corporation (the “Company”) elected Dominic J. Caruso as a new director, effective September 12, 2018. Mr. Caruso’s term as a director will expire at the Company’s 2019 Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with the Company’s majority voting standard. The Board increased from eight to nine members in connection with Mr. Caruso’s election. Mr. Caruso, age 61, retired as Executive Vice President and Chief Financial Officer of Johnson & Johnson in August 2018, having served in that role since 2007. He previously served in other leadership positions at Johnson & Johnson, including as Senior Vice President of Centocor, Inc. and Vice President of Johnson & Johnson’s Group Finance organization. Mr.

On July 31, 2018, McKesson Corporation (the “Company”) announced that it has appointed Brian S. Tyler as its President and Chief Operating Officer, effective August 2, 2018. Mr. Tyler, age 51, is currently Chairman of the Management Board of McKesson Europe AG and has served in that role since 2017. Mr. Tyler served as the Company’s President and Chief Operating Officer of McKesson Europe from 2016 to 2017, the Company’s President of North American Pharmaceutical Distribution and Services from 2015 to 2016, and as the Company’s Executive Vice President, Corporate Strategy & Business Development from 2012 to 2015. Mr. Tyler previously served in various other leadership roles in the Company, including as President of U.S. Pharmaceutical, President of McKesson Medical-Surgical, and President of McKesson Specialty Health. Mr.

On July 9, 2018, Erin M. Lampert, Senior Vice President and Chief Accounting Officer, notified McKesson Corporation (“McKesson” or the “Company”) of her intention to resign from her role effective July 25, 2018. She will remain with the Company for a transition period ending in early August. The Company plans to appoint Sundeep Reddy as Senior Vice President, Corporate Controller effective July 25, 2018. In that role, Mr. Reddy will serve as our principal accounting officer. Mr. Reddy, age 45, is currently Senior Vice President, Assistant Controller. He joined McKesson in 2013 as Vice President & Controller, McKesson Technology Solutions, progressing to his current role, where he leads a team focused on global consolidations and reporting, external (SEC) reporting, technical accounting, corporate general ledger and financial applications. Mr.

On April 24, 2018, the Board of Directors (the “Board”) of McKesson Corporation (the “Company”), upon recommendation of the Governance Committee, elected Bradley E. Lerman, as a new director, effective April 24, 2018. Mr. Lerman’s term as a director will expire at the Company’s 2018 Annual Meeting of Stockholders unless he is renominated as a director, and elected by stockholders at the annual meeting in accordance with the Company’s majority voting standard. The size of the Board was increased from eight to nine members in connection with Mr. Lerman’s election. Mr. Lerman, age 61, has been Senior Vice President, General Counsel and Corporate Secretary of Medtronic plc, a global medical technology, services, and solutions company, since January 2015 and of Medtronic, Inc. since May 2014.

As previously reported by McKesson Corporation (the “Company”) in a Current Report on Form 8-K filed with the Securities and Exchange Commission on December 18, 2017 (the “Initial Form 8-K”), the Company announced that, effective January 1, 2018, Britt Vitalone would serve as its Executive Vice President and Chief Financial Officer. At the time of the filing of the Initial Form 8-K, the Compensation Committee (the “Committee”) of the Board of Directors of the Company had not determined Mr. Vitalone’s compensation in connection with his new role. The Company is filing this Current Report on Form 8-K/A to amend the Initial Form 8-K to report that on January 4, 2018, the Committee approved compensation arrangements for Mr. Vitalone. Effective as of January 1, 2018, Mr.

On December 18, 2017, McKesson Corporation (the “Company”) announced that it will appoint Britt Vitalone as its Executive Vice President and Chief Financial Officer effective January 1, 2018. Mr. Vitalone will replace James A. Beer who will be leaving the Company early next calendar year to become chief financial officer of Atlassian Corporation PLC. Mr. Vitalone, age 48, is currently Senior Vice President and Chief Financial Officer of U.S. Pharmaceutical and McKesson Specialty Health, which includes responsibility for all day-to-day financial and accounting operations including long range planning and financial oversight of new strategic initiatives. From 2012 to 2014, Mr.

On March 31, 2017, Patrick J. Blake resigned as Executive Vice President and Group President of McKesson Corporation (the “Company”). Mr. Blake was identified as a “named executive officer” in the Company’s 2016 definitive proxy statement, which was filed with the Securities and Exchange Commission on June 17, 2016. While he no longer will serve as an executive officer, Mr. Blake will continue to assist in the evaluation of strategic alternatives for the Company’s Enterprise Information Solutions business.

On May 19, 2016, McKesson Corporation (the “Company”) announced the appointment of Erin M. Lampert as Senior Vice President and Controller, effective June 1, 2016. Ms. Lampert succeeds Nigel A. Rees, who is retiring. The Company also announced the promotion of Craig Mercer to succeed Ms. Lampert as Senior Vice President, Investor Relations. Ms. Lampert, age 45, has been with the Company since 2005. Prior to her recent promotion, Ms. Lampert served as Senior Vice President, Investor Relations from 2012 to the present. She previously served as Senior Vice President of Financial Planning and Analysis from 2007 to 2012 and Vice President, Mergers and Acquisitions Finance from 2005 to 2007. Prior to joining the Company, Ms. Lampert held various leadership positions at JDS Uniphase, Island Graphics, and Ingersoll Rand Corporation. Ms.